Tomonori Takeuchi

Tomonori Takeuchi

Auto-generated profile, based on publicly available information

Tomonori Takeuchi

Department of Internal Medicine, University of New Mexico, Albuquerque, New Mexico

Research Focus & Metrics

Academic Career Length

3Years (2024-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
28 March 2025 in Journal of the American Society of Nephrology
Verified
Journal Article
Closed access
ACAugusto Cama-Olivares
Augusto Cama-Olivares
CBChloe Braun
Chloe Braun
TTTomonori Takeuchi
Tomonori Takeuchi
EOEmma C. O'HAgan
Emma C. O'HAgan
KKKathryn A. Kaiser
Kathryn A. Kaiser
JNJavier A. Neyra
Javier A. Neyra
Key Points: Pooled discrimination metrics were acceptable (area under the receiver operating characteristic curve >0.70) for all AKI risk classification categories in both internal and external validation. Better performance was observed in most recently published studies and those with a low or unclear risk of bias. Significant heterogeneity in patient populations, definitions, clinical predictors, and methods limit implementation in real-world clinical scenarios. Background: Artificial intelligence through machine learning models seems to provide accurate and precise AKI risk classification in some clinical settings, but their performance and implementation in real-world settings has not been established. Methods: PubMed, Excerpta Medica (EMBASE) database, Web of Science, and Scopus were searched until August 2023. Articles reporting on externally validated models for prediction of AKI onset, AKI severity, and post-AKI complications in hospitalized adult and pediatric patients were searched using text words related to AKI, artificial intelligence, and machine learning. Two independent reviewers screened article titles, abstracts, and full texts. Areas under the receiver operating characteristic curves (AUCs) were used to compare model discrimination and pooled using a random-effects model. Results: Of the 4816 articles initially identified and screened, 95 were included, representing 3.8 million admissions. The Kidney Disease Improving Global Outcomes (KDIGO)-AKI criteria were most frequently used to define AKI (72%). We identified 302 models, with the most common being logistic regression (37%), neural networks (10%), random forest (9%), and eXtreme gradient boosting (9%). The most frequently reported predictors of hospitalized incident AKI were age, sex, diabetes, serum creatinine, and hemoglobin. The pooled AUCs for AKI onset were 0.82 (95% confidence interval, 0.80 to 0.84) and 0.78 (95% confidence interval, 0.76 to 0.80) for internal and external validation, respectively. Pooled AUCs across multiple clinical settings, AKI severities, and post-AKI complications ranged from 0.78 to 0.87 for internal validation and 0.73 to 0.84 for external validation. Although data were limited, results in the pediatric population aligned with those observed in adults. Between-study heterogeneity was high for all outcomes (I 2 >90%), and most studies presented high risk of bias (86%) according to the Prediction Model Risk of Bias Assessment Tool. Conclusions: Most externally validated models performed well in predicting AKI onset, AKI severity, and post-AKI complications in hospitalized adult and pediatric populations. However, heterogeneity in clinical settings, study populations, and predictors limits their generalizability and implementation at the bedside.

30 September 2024 in Kidney360
Verified
Journal Article
Open access
ACAugusto Cama-Olivares
Augusto Cama-Olivares
TOTianqi Ouyang
Tianqi Ouyang
TTTomonori Takeuchi
Tomonori Takeuchi
SHShelsea A. St. Hillien
Shelsea A. St. Hillien
JRJevon E. Robinson
Jevon E. Robinson
HCHRS-HARMONY Consortium
HRS-HARMONY Consortium
Key Points: In patients with cirrhosis and AKI requiring renal replacement therapy (RRT), hepatorenal syndrome-AKI was not associated with an increased 90-day mortality when compared with other AKI etiologies. Etiology of AKI may not be a critical factor regarding decisions to trial RRT in acutely ill patients with cirrhosis and AKI. Although elevated, mortality rates in this study are comparable with those reported in general hospitalized patients with AKI requiring RRT. Background: While AKI requiring renal replacement therapy (AKI-RRT) is associated with increased mortality in heterogeneous inpatient populations, the epidemiology of AKI-RRT in hospitalized patients with cirrhosis is not fully known. Herein, we evaluated the association of etiology of AKI with mortality in hospitalized patients with cirrhosis and AKI-RRT in a multicentric contemporary cohort. Methods: This is a multicenter retrospective cohort study using data from the HRS-HARMONY consortium, which included 11 US hospital network systems. Consecutive adult patients admitted in 2019 with cirrhosis and AKI-RRT were included. The primary outcome was 90-day mortality, and the main independent variable was AKI etiology, classified as hepatorenal syndrome (HRS-AKI) versus other (non–HRS-AKI). AKI etiology was determined by at least two independent adjudicators. We performed Fine and Gray subdistribution hazard analyses adjusting for relevant clinical variables. Results: Of 2063 hospitalized patients with cirrhosis and AKI, 374 (18.1%) had AKI-RRT. Among them, 65 (17.4%) had HRS-AKI and 309 (82.6%) had non–HRS-AKI, which included acute tubular necrosis in most cases (62.6%). Continuous renal replacement therapy was used as the initial modality in 264 (71%) of patients, while intermittent hemodialysis was used in 108 (29%). The HRS-AKI (versus non–HRS-AKI) group received more vasoconstrictors for HRS management (81.5% versus 67.9%), whereas the non–HRS-AKI group received more mechanical ventilation (64.3% versus 50.8%) and more continuous renal replacement therapy (versus intermittent hemodialysis) as the initial RRT modality (73.9% versus 56.9%). In the adjusted model, HRS-AKI (versus non–HRS-AKI) was not independently associated with increased 90-day mortality (subdistribution hazard ratio, 1.36; 95% confidence interval, 0.95 to 1.94). Conclusions: In this multicenter contemporary cohort of hospitalized adult patients with cirrhosis and AKI-RRT, HRS-AKI was not independently associated with an increased risk of 90-day mortality when compared with other AKI etiologies. The etiology of AKI appears less relevant than previously considered when evaluating the prognosis of hospitalized adult patients with cirrhosis and AKI requiring RRT.

11 September 2024 in Clinical Journal of the American Society of Nephrology
Verified
Journal Article
Closed access
LGLama Ghazi
Lama Ghazi
VPVibhu Parcha
Vibhu Parcha
TTTomonori Takeuchi
Tomonori Takeuchi
CBCatherine R. Butler
Catherine R. Butler
EBElizabeth Baker
Elizabeth Baker
JNJavier A. Neyra
Javier A. Neyra
Key Points: AKI is common among hospitalized patients. However, the contribution of neighborhood social determinants of health to AKI risk is not known. We found that among 26,769 hospitalized patients, 26% developed AKI. Patients who lived in the most disadvantaged areas (highest tertile of Area Deprivation Index) had a 10% greater odds of developing AKI than counterparts in the lowest Area Deprivation Index tertile. Patients who lived in rural areas had 25% greater odds of not recovering from AKI by hospital discharge. This study demonstrates an association between neighborhood disadvantage and rurality on the development of AKI and lack of recovery from AKI. Further work is needed to understand the mechanisms of these associations and to develop community-level interventions to mitigate the health care burden of AKI for disadvantaged populations. Background: AKI is common among hospitalized patients. However, the contribution of social determinants of health (SDOH) to AKI risk remains unclear. This study evaluated the association between neighborhood measures of SDOH and AKI development and recovery during hospitalization. Methods: This is a retrospective cohort study of adults without ESKD admitted to a large Southern US health care system from October 2014 to September 2017. Neighborhood SDOH measures included (1) socioeconomic status: Area Deprivation Index (ADI) scores, (2) food access: Low-Income, Low-Access scores, (3) rurality: Rural–Urban Commuting Area scores, and (4) residential segregation: dissimilarity and isolation scores. The primary study outcome was AKI on the basis of serum creatinine Kidney Disease Improving Global Outcomes criteria. Our secondary outcome was lack of AKI recovery (requiring dialysis or elevated serum creatinine at discharge). The association of SDOH measures with AKI was evaluated using generalized estimating equation models adjusted for demographics and clinical characteristics. Results: Among 26,769 patients, 26% developed AKI during hospitalization. Compared with those who did not develop AKI, those who developed AKI were older (median 60 versus 57 years), more commonly men (55% versus 50%), and more commonly self-identified as Black (38% versus 33%). Patients residing in most disadvantaged neighborhoods (highest ADI tertile) had 10% (95% confidence interval, 1.02 to 1.19) greater adjusted odds of developing AKI during hospitalization than counterparts in least disadvantaged areas (lowest ADI tertile). Patients living in rural areas had 25% higher adjusted odds of lack of AKI recovery by hospital discharge (95% confidence interval, 1.07 to 1.46). Food access and residential segregation were not associated with AKI development or recovery. Conclusions: Hospitalized patients from the most socioeconomically disadvantaged neighborhoods and from rural areas had higher odds of developing AKI and not recovering from AKI by hospital discharge, respectively. A better understanding of the mechanisms underlying these associations is needed to inform interventions to reduce AKI risk during hospitalization among disadvantaged populations.

4 September 2024 in Kidney360
Verified
Journal Article
Open access
JCJason A. Collett
Jason A. Collett
AFAlexander H. Flannery
Alexander H. Flannery
LLLucas J. Liu
Lucas J. Liu
TTTomonori Takeuchi
Tomonori Takeuchi
DBDavid P. Basile
David P. Basile
JNJavier A. Neyra
Javier A. Neyra
Key Points: IL-17A was higher in patients with AKI versus without AKI during hospitalization and up to 1-year postdischarge. IL-17A was higher in patients with progression of kidney disease but not independently associated with subsequent progression of kidney disease. Background: AKI is associated with increased mortality and new or progressive CKD. Inflammatory cells play an important role in acute organ injury. We previously demonstrated that serum IL-17A levels were significantly elevated in critically ill patients with AKI and independently associated with hospital mortality. We hypothesize that IL-17A levels are elevated in hospitalized patients with AKI at diagnosis, and sustained elevation after discharge is associated with subsequent CKD incidence or progression. Methods: This was an observational convenience sampling study of hospital survivors of stage 2 or 3 AKI and controls without AKI from the Assessment, Serial Evaluation, and Subsequent Sequelae of AKI study. Patients were classified as progression or nonprogression on the basis of a composite of CKD incidence, progression, or ESKD. IL-17A levels were evaluated with S-Plex assay (Meso Scale Discovery) at 0 (during hospitalization), 3, and 12 months postdischarge and analyzed along with clinical and biomarker data up to 84 months after discharge. Results: Among 171 AKI and 175 non-AKI participants, IL-17A levels were elevated in AKI versus non-AKI patients at 0-, 3-, and 12-month time points (P < 0.05 for all comparisons). Furthermore, IL-17A levels were elevated in the progression versus nonprogression group at the 3- and 12-month time points for outcomes occurring at 3–6 and 12–84 months, respectively (P < 0.05 for both). In adjusted multivariable models, IL-17A levels were not independently associated with progression of kidney disease. IL-17A levels were positively correlated with kidney disease and immune activation biomarkers at all time points (P < 0.001). Conclusions: IL-17A was higher in patients with AKI versus without AKI during hospitalization and up to 1-year postdischarge. IL-17A was higher in patients with progression of kidney disease after hospitalization, but not independently associated with subsequent progression of kidney disease in fully adjusted models.

12 September 2025 in Clinical Journal of the American Society of Nephrology
Verified
Journal Article
Open access
TTTomonori Takeuchi
Tomonori Takeuchi
SBSeda Babroudi
Seda Babroudi
LGLama Ghazi
Lama Ghazi
EBElizabeth Baker
Elizabeth Baker
GOGabriela Oates
Gabriela Oates
JNJavier A. Neyra
Javier A. Neyra
Key Points: Only one third of intensive care unit patients who developed severe AKI received Kidney Disease Improving Global Outcomes–recommended follow-up care within 3 months of AKI. Both individual-level and neighborhood-level socioeconomic disadvantages are associated with decreased post-AKI follow-up care. Background: Individual-level and neighborhood-level social determinants of health (SDOH) measures have been associated with higher incidence of AKI, lower likelihood of recovery, and higher risk of mortality after AKI. The association of SDOH measures with posthospitalization AKI follow-up care is unknown. Methods: Using a retrospective cohort design, we evaluated the association of individual-level (insurance status, race, ethnicity) and neighborhood-level (socioeconomic deprivation, rurality, residential segregation, and social vulnerability to natural or human-caused disasters) SDOH measures with receipt of posthospitalization follow-up for AKI within 3 months of hospital discharge among intensive care unit (ICU) survivors with AKI stage 2 or 3 hospitalized between 2012 and 2023 at a major academic medical center. The primary outcome, posthospitalization AKI follow-up, was defined as the occurrence of at least one of the following within 3 months of hospital discharge: a nephrology outpatient visit, serum creatinine measurement, or urine protein measurement. We used pooled logistic regression models with inverse probability of censoring weighting to adjust for demographics, comorbidities, and hospitalization characteristics and to account for the competing risks of death, rehospitalization, or dialysis initiation. Results: Among 13,392 adult ICU survivors with AKI stages 2 or 3, 5970 (45%) were female, 4488 (34%) were of Black race, and 1561 (12%) were uninsured. A total of 7316 (61%) received posthospitalization follow-up for AKI within 3 months of hospital discharge. Uninsured individuals (adjusted odds ratio [aOR], 0.77; 95% confidence interval [CI], 0.70 to 0.84), individuals residing in a neighborhood with greater socioeconomic deprivation (aOR, 0.86; 95% CI, 0.81 to 0.92), greater rurality (aOR, 0.86; 95% CI, 0.81 to 0.92), greater segregation (aOR, 0.92; 95% CI, 0.87 to 0.98), and greater social vulnerability (aOR, 0.83; 95% CI, 0.77 to 0.89) all experienced significantly lower odds of posthospitalization AKI care. Conclusions: Both individual-level and neighborhood-level SDOH were associated with lower odds of post-AKI follow-up among ICU survivors with severe AKI.

31 July 2026 in Clinical Journal of the American Society of Nephrology
Verified
Journal Article
Closed access
Dilaram AcharyaDilaram Acharya
Dilaram Acharya
SBSeda Babroudi
Seda Babroudi
UEUdeme E. Ekrikpo
Udeme E. Ekrikpo
TTTomonori Takeuchi
Tomonori Takeuchi
LGLama Ghazi
Lama Ghazi
JNJavier A. Neyra
Javier A. Neyra
Key Points: During follow-up, 326 (1%) critical illness survivors with AKI developed ESKD; 2723 (9%) died. Black race and lack of health insurance were independently associated with higher risk of developing ESKD. Residence in a socioeconomically deprived neighborhood was independently associated with higher risk of ESKD. Background: Adverse social determinants of health (SDOHs) are associated with higher risk of AKI. This study evaluated the association of individual- and neighborhood-level SDOHs with incident ESKD among intensive care unit (ICU) survivors of AKI. Methods: Thirty thousand four hundred ninety-eight adult ICU survivors of AKI at a major academic medical center between January 1, 2012, and December 31, 2022, were included. Individual-level SDOHs (race, ethnicity, and insurance status) were obtained from the hospital electronic health record, whereas neighborhood-level SDOHs (Area Deprivation Index among others) were derived from census-based indices. ESKD was defined by kidney failure with an eGFR <15 ml/min per 1.73 m 2 or the initiation of KRT, including maintenance dialysis or kidney transplantation. Association of individual- and neighborhood-level SDOHs with incident ESKD was evaluated using multivariable cause-specific Cox proportional hazards models adjusting for clinical factors. Results: The median age was 58 years, 40% were women, 31% were Black, and 12% were uninsured. The median follow-up time was 730 days, during which 326 (1%) patients developed ESKD and 2723 (9%) died. In adjusted models, Black race was associated with a higher hazard of ESKD compared with White race (adjusted hazard ratio [aHR], 1.43, 95% confidence interval [CI], 1.05 to 1.94), whereas having health insurance was associated with a lower hazard of ESKD (aHR, 0.60; 95% CI, 0.39 to 0.92). Higher neighborhood-level socioeconomic disadvantage was also independently associated with higher risk of ESKD (Area Deprivation Index tertile 2: aHR, 1.42; 95% CI, 1.01 to 2.00; tertile 3: aHR, 1.58; 95% CI, 1.08 to 2.33). Conclusions: Black race, lack of health insurance, and residence in socioeconomically deprived neighborhoods were independently associated with a higher hazard of incident ESKD among ICU survivors of AKI. Standardized SDOHs assessment in clinical practice may improve risk stratification of ESKD and identify AKI survivors most likely to benefit from postdischarge interventions.